發表日期
|
期刊
|
論文名稱
|
使用之細胞種類
|
2024/1/12
|
Cancer Discovery
|
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
|
T cells
|
2024/1/11
|
Nature Biotechnology
|
In vivo human T cell engineering with enveloped delivery vehicles
|
Cryo PBMCs,
CD34+ cell
|
2023/11/30
|
Nature Biomedical Engineering
|
High-dimensional multi-pass flow cytometry via spectrally encoded cellular barcoding
|
Cryo PBMCs
|
2023/11/13
|
Nature Medicine
|
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial
|
PBMCs
|
2023/10/12
|
Cell
|
Mitigation of chromosome loss in clinical CRISPRCas9-engineered T cells
|
PBMCs
|
2023/8/16
|
Advanced Science
|
Anti-PD-1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2-Positive Gastric Cancer through Gasdermin B-Cleavage Induced Pyroptosis
|
PBMCs
|
2023/8/3
|
Nature Biotechnology
|
Systematic benchmarking of single-cell ATAC-sequencing protocols
|
Cryo PBMCs
|
2023/7/5
|
Cancer Immunology Research
|
CD28 Costimulatory Domain–Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function
|
Cryo PBMCs
|
2023/3/6
|
Nature Biotechnology
|
Microfluidics-free single-cell genomics with templated emulsification
|
Cryo PBMCs
|
2022/10/26
|
Nature
|
Functional antibodies exhibit light chain coherence
|
PBMCs
|
2022/9/15
|
Nature Biotechnology
|
Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencing
|
Cryo PBMCs
|
2022/9/10
|
Nature Communications
|
Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen
|
Leukopaks
|
2022/8/25
|
Nature Biotechnology
|
High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails
|
Leukopaks
|
2022/7/30
|
Nature Communications
|
RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R
|
Leukopaks
|
2022/7/26
|
Nature Communications
|
T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
|
PBMCs
|
2022/6/30
|
Nature Communications
|
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
|
Cryo PBMCs, NK
|
2022/4/28
|
Nature Communications
|
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
|
PBMCs
|
2022/3/17
|
Molecular Therapy
|
CD3 engagement as a new strategy for allogeneic “off-the-shelf” T cell therapy
|
Leukopaks
|
2022/3/7
|
Nature Cancer
|
An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy
|
PBMCs
|
2022/2/9
|
Nature Communications
|
Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling
|
CD4+ T, CD8+ T,
Treg
|
2021/10/21
|
Nature Biotechnology
|
Single-cell profiling of proteins and chromatin accessibility using PHAGE-ATAC
|
CD8+ T,
Cryo PBMCs
|
2021/7/12
|
Journal for ImmunoTherapy
of Cancer
|
Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies
|
CD3+ Pan T
|
2021/6/1
|
Cancer Research
|
Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models
|
Leukopaks
|
2021/4/1
|
Molecular Therapy
|
Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy
|
Cryo PBMCs
|
2021/1/4
|
Cancer Immunology Research
|
CD28 Costimulatory Domain–Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function
|
PBMCs
|
2020/7/3
|
Cellular &
Molecular Immunology
|
ERMAP is a B7 family-related molecule that negatively regulates T cell and macrophage responses
|
CD3+ Pan T
|